Sign in to continue:

Thursday, February 5th, 2026
Stock Profile: CHEK
CHEK Logo

Check-Cap Ltd. (CHEK)

Market: NMS | Currency: USD

Address: Check-Cap Building

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Show more




📈 Check-Cap Ltd. Historical Chart






📊 Statistics





💰 Dividend History


Year Annual Yield (%) Total Amount Current Yield (%) Ex Date Pay Date Particulars
2022 - $0.050000 - 2022-11-25 - Stock split
Total Amount for 2022: $0.050000
2018 - $0.083333 - 2018-04-04 - Stock split
Total Amount for 2018: $0.083333


📅 Earnings & EPS History for Check-Cap Ltd.


DateReported EPS
2023-11-27-0.43
2023-08-04-0.94
2023-05-11-0.76
2023-03-31-0.63
2022-11-30-0.8
2022-08-31-0.8
2022-06-01-1.2
2022-04-06-1.2
2021-11-03-0.8
2021-08-05-1.2
2021-05-12-1
2021-03-18-1.2
2020-11-18-1.8
2020-08-06-2.4
2020-05-27-6.8
2020-03-06-9.2
2019-11-06-8.4
2019-08-07-8.2
2019-05-13-8.8
2019-03-28-11.6
2018-11-05-10
2018-07-31-14
2018-05-17-25.4
2018-04-04-24.4
2017-11-06-31.2




📰 Related News & Research


No related articles found for "checkcap ltd".